Dietrich A Stephan Neu Base Therapeutics, Inc. (NBSE) insider trading activity

NBSE Quotes by TradingView

Dietrich A Stephan is Founder and CEO of NeuBase Therapeutics, Inc.. Currently has a direct ownership of 93,234 shares of NBSE, which is worth approximately $0. The most recent transaction as insider was on Aug 02, 2023, when has been sold 93,234 shares (Common Stock) at a price of $0.02 per share, resulting in proceeds of $1,864. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 93.2K
0% 3M change
0% 12M change
Total Value Held $0

Dietrich A Stephan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 02 2023
BUY
Exercise of conversion of derivative security
$1,864 $0.02 p/Share
93,234 Added 50.0%
93,234 Common Stock
Mar 16 2023
BUY
Grant, award, or other acquisition
-
153,000 Added 50.0%
153,000 Common Stock
Feb 13 2023
BUY
Exercise of conversion of derivative security
-
655,000 Added 30.8%
1,471,775 Common Stock
Sep 28 2022
BUY
Exercise of conversion of derivative security
-
750,000 Added 47.87%
816,775 Common Stock
Dec 31 2021
BUY
Exercise of conversion of derivative security
-
42,250 Added 38.75%
66,775 Common Stock
Apr 26 2021
BUY
Open market or private purchase
$60,000 $5.0 p/Share
12,000 Added 32.85%
24,525 Common Stock
DAS

Dietrich A Stephan

Founder and CEO
Pittsburgh, PA

Track Institutional and Insider Activities on NBSE

Follow NeuBase Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBSE shares.

Notify only if

Insider Trading

Get notified when an Neu Base Therapeutics, Inc. insider buys or sells NBSE shares.

Notify only if

News

Receive news related to NeuBase Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NBSE